Related Experiment Video
Updated: Nov 9, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Sudden death of COVID-19 patients in Wuhan, China: A retrospective cohort study
Nan Yang1, Kunming Tian2, Meng Jin3
1Department of Epidemiology and Biostatistics, Key Laboratory for Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, China.
Insights
Sudden death in COVID-19 patients, often linked to severe inflammation and organ dysfunction, particularly affecting the liver and heart, warrants further investigation. Understanding these risk factors is crucial for patient outcomes.
Area of Science:
- Medicine
- Infectious Diseases
- Critical Care
Background:
- The emergence of coronavirus disease 2019 (COVID-19) in late 2019 led to a significant global health crisis.
- COVID-19 caused approximately 4000 deaths in China alone during the initial outbreak.
- Characterizing clinical features and identifying risk factors for sudden death in COVID-19 patients is essential.
Purpose of the Study:
- To systematically analyze the clinical characteristics of deceased COVID-19 patients.
- To determine the risk factors associated with sudden death among COVID-19 fatalities.
- To compare clinical features between sudden and non-sudden death groups in COVID-19.
Main Methods:
- A retrospective study of 281 deceased COVID-19 patients admitted to Tongji hospital between January 22 and March 23, 2020.
- Patients were categorized into sudden death (died within 24 hours of admission) and non-sudden death groups.
- Logistic regression analysis was employed to identify risk factors for sudden death.
Main Results:
- Sudden death occurred in 10% of the deceased patients (28 out of 281).
- Sudden deaths showed higher fatigue incidence, lower eosinophil counts, and elevated levels of inflammatory markers (procalcitonin, CRP) and organ function indicators (ALT, AST, LDH, BNP).
- No significant differences were observed in gender, age, chest CT findings, or comorbidities between the groups.
Conclusions:
- Sudden death in COVID-19 patients is associated with more severe systemic inflammation and multi-organ dysfunction, particularly impacting liver and heart function.
- These findings highlight distinct clinical profiles in sudden COVID-19 fatalities.
- Further research is recommended to validate these observations and elucidate underlying mechanisms.
Background:
In December 2019, coronavirus disease 2019 (COVID-19) emerged in Wuhan city and rapidly spread throughout China. So far, it has caused ~ 4000 deaths in this country. We aimed to systematically characterize clinical features and determine risk factors of sudden death for COVID-19 patients.
Methods:
Deceased patients with COVID-19 in Tongji hospital from January 22 to March 23, 2020 were extracted. Patients who died within 24 hours after admission were identified as sudden deaths, and the others formed non-sudden deaths. The differences in clinical characteristics between the two groups were estimated. Risk factors associated with sudden deaths were explored by logistic regression.
Results:
281 deceased patients were enrolled in this study. Sudden death occurred in 28 (10.0%) patients, including 4 (14.3%) admitted to the intensive care unit. Fatigue was more common in sudden deaths (11, 47.8%) than in non-sudden deaths (40, 17.2%). Both the count and percentage of eosinophils were lower in sudden deaths than that in non-sudden deaths (P = 0.006 and P = 0.004). Compared with non-sudden deaths, sudden deaths had higher plasma levels of procalcitonin, C-reactive protein, D-dimer, alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transferase, lactate dehydrogenase, alkaline phosphatase and N-terminal pro-brain natriuretic peptide. There were not significant differences in gender, age, chest CT image features and comorbidities observed.
Conclusions:
The differences between the two groups suggested more severe systemic inflammation, multi-organ dysfunction, especially impaired liver and heart function in COVID-19 patients who died suddenly after admission. More researches are needed to verify these points.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-III
Bias in Epidemiological Studies
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...

